Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Tonix Pharmaceuticals Holding Corp’s current trading price is -97.77% away from its 52-week high, while its distance from the 52-week low is
Tonix Pharmaceuticals Holding Corp’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $13.76 on 01/04/24, with the lowest value being $0.12 on 10/03/24. 52-week price history of TNXP Stock Analyzing the 52-week price history of a
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -97.38% this year. Over the last six months, there has been a stronger performance of -51.59%.
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Tonix Pharmaceuticals Holding Corp’s current trading price is -97.19% away from its 52-week high, while its distance from the 52-week low is
Tonix Pharmaceuticals Holding Corp experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $22.14 on 12/19/23, while the lowest price for the same period was registered at $0.12 on 10/03/24. 52-week price history of TNXP Stock Studying
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -98.58%. However, over the past six months, we’ve seen a
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -98.53%.However, over the last six months, we can see a
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -98.51% since the start of this calendar year. Looking back over
While in 2023, healthcare lagged despite market optimism, the industry in 2024, is poised for a resurgence. With innovative breakthroughs like GLP-1 drugs and rising US prescriptions, healthcare offers enticing prospects for investors seeking growth. Let’s explore three phenomenal healthcare stocks primed for a boom
All rights reserved © 2024, Powered By Smart TechOne
